Related Experiment Video
Updated: Sep 7, 2025
07:01
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.1K
Mechanisms Underlying Aquaporin-4 Subcellular Mislocalization in Epilepsy
1Division of Biomedical Sciences, School of Medicine, University of California, Riverside, Riverside, CA, United States.
Frontiers in Cellular Neuroscience
|June 23, 2022
Summary
Aquaporin-4 (AQP4) water channels in the brain are crucial for controlling seizures in epilepsy. This review explores how AQP4 mislocalization contributes to epilepsy development and seizure activity.
Area of Science:
- Neuroscience
- Cell Biology
- Epilepsy Research
Background:
- Epilepsy is a chronic neurological disorder defined by recurrent, unprovoked seizures.
- Astrocytic channels and transporters are implicated in seizure generation and epileptogenesis.
- Aquaporin-4 (AQP4), an astrocyte water channel, plays a critical role in brain homeostasis.
Approach:
- This review synthesizes current research on the role of AQP4 in epilepsy.
- It examines the mechanisms behind AQP4 dysregulation and mislocalization.
- Evidence from both clinical and preclinical studies is evaluated.
Key Points:
- AQP4 is known to mislocalize from astrocyte endfeet to the neuropil in epilepsy.
- This subcellular redistribution of AQP4 impacts neuronal hyperexcitability.
- Understanding AQP4's role is key to uncovering epilepsy mechanisms.
Conclusions:
- AQP4 dysregulation and mislocalization are significant factors in epilepsy.
- Further investigation into AQP4's function can reveal new therapeutic targets.
- Targeting AQP4 may offer novel strategies for epilepsy treatment.
More Related Videos
Related Concept Videos
01:25Aquaporins
5.0K
Aquaporins or AQPs are a family of integral membrane proteins whose primary function is to transport water, while some called aquaglyceroporins also transport glycerol. In addition, aquaporins have also been suspected to be involved in transporting volatile substances, such as carbon dioxide and ammonia, across membranes. Such AQPs that act as gas channels are often highly expressed in cells involved in the gaseous exchange, such as red blood cells, epithelial cells, and pulmonary capillaries.
5.0K
01:24Epilepsy and Seizures: Overview
273
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
273
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
432
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
432
01:20Antiepileptic Drugs: Potassium Channel Activators
270
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
270
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
619
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
619
01:14Antiepileptic Drugs: Glutamate Antagonists
504
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
504